{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:57:31Z","timestamp":1760889451344,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Chinese High-tech R&D (863)Program","award":["2011AA03010"],"award-info":[{"award-number":["2011AA03010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0654-7","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T13:24:07Z","timestamp":1502803447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polymer-free dual drug-eluting stents evaluated in a porcine model"],"prefix":"10.1186","volume":"17","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunshui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-860X","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"654_CR1","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","volume":"373","author":"SG Ellis","year":"2015","unstructured":"Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, et al. Everolimus-eluting bioresorbable scaffolds for coronary artery disease. N Engl J Med. 2015;373:1905\u201315.","journal-title":"N Engl J Med"},{"key":"654_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"PW Serruys","year":"2015","unstructured":"Serruys PW, Chevalier B, Dudek D, Cequier A, Carri\u00e9 D, Iniguez A, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomized controlled trial. Lancet. 2015;385:43\u201354.","journal-title":"Lancet"},{"key":"654_CR3","doi-asserted-by":"crossref","first-page":"26776","DOI":"10.1074\/jbc.274.38.26776","volume":"274","author":"F Vi\u00f1als","year":"1999","unstructured":"Vi\u00f1als F, Chambard JC, Pouyss\u00e9gur J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem. 1999;274:26776\u201382.","journal-title":"J Biol Chem"},{"key":"654_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2184.2006.00375.x","volume":"39","author":"TG Chen","year":"2006","unstructured":"Chen TG, Chen JZ, Wang XX. Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood. Cell Prolif. 2006;39:117\u201325.","journal-title":"Cell Prolif"},{"key":"654_CR5","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435\u201341.","journal-title":"Circulation"},{"key":"654_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124021","volume":"10","author":"J Liu","year":"2015","unstructured":"Liu J, Li M, Lu H, Qiao W, Xi D, Luo T, et al. Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis. PLoS One. 2015;10:e0124021. doi: 10.1371\/journal.pone.0124021 .","journal-title":"PLoS One"},{"key":"654_CR7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.0000062682.40051.43","volume":"107","author":"AK Lau","year":"2003","unstructured":"Lau AK, Leichtweis SB, Hume P, Mashima R, Hou JY, Chaufour X, et al. Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation. 2003;107:2031\u20136.","journal-title":"Circulation"},{"key":"654_CR8","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1172\/JCI117953","volume":"95","author":"JF Keaney Jr","year":"1995","unstructured":"Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 1995;95:2520\u20139.","journal-title":"J Clin Invest"},{"key":"654_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1291\/hypres.27.311","volume":"27","author":"T Tagawa","year":"2004","unstructured":"Tagawa T, Urabe Y, Kimura Y, Suzuki S, Ono H, Takeda K. Long-term treatment with probucol improves endothelial function in patients with coronary artery disease. Hypertens Res. 2004;27:311\u20138.","journal-title":"Hypertens Res"},{"key":"654_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ccd.25129","volume":"83","author":"M Yu","year":"2014","unstructured":"Yu M, Xu B, Kandzari DE, Wu Y, Yan H, Chen J, et al. First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in human BICARE trial. Catheter Cardiovasc Interv. 2014;83:405\u201311.","journal-title":"Catheter Cardiovasc Interv"},{"key":"654_CR11","first-page":"289","volume":"27","author":"B Zhang","year":"2014","unstructured":"Zhang B, Chen M, Zheng B, Wang XG, Wang XT, Fan YY, et al. A novel high nitrogen nickel-free coronary stents system: evaluation in a porcine model. Biomed Environ Sci. 2014;27:289\u201394.","journal-title":"Biomed Environ Sci"},{"key":"654_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.carrev.2008.11.003","volume":"10","author":"JS Mills","year":"2009","unstructured":"Mills JS, N'diaye CS, Yow E, Urtz M, Povsic TJ, Greenfield JC, et al. Preliminary observations using optical coherence tomography to assess neointimal coverage of a metal stent in a porcine model. Cardiovasc Revasc Med. 2009;10:229\u201335.","journal-title":"Cardiovasc Revasc Med"},{"key":"654_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jcin.2008.08.004","volume":"1","author":"MC John","year":"2008","unstructured":"John MC, Wessely R, Kastrati A, Sch\u00f6mig A, Joner M, Uchihashi M, et al. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. JACC Cardiovasc Interv. 2008;1:535\u201344.","journal-title":"JACC Cardiovasc Interv"},{"key":"654_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCINTERVENTIONS.109.877522","volume":"3","author":"N Tada","year":"2010","unstructured":"Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, et al. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Circ Cardiovasc Interv. 2010;3:174\u201383.","journal-title":"Circ Cardiovasc Interv"},{"key":"654_CR15","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.3760\/cma.j.issn.0366-6999.20123267","volume":"126","author":"M Chen","year":"2013","unstructured":"Chen M, Zheng B, Wu Z, Peng HY, Wang XG, Zhang B, et al. Efficacy and safetyof a novel nano-porous polymer-free sirolimus-eluting stent in pigs. Chin Med J. 2013;126:4731\u20135.","journal-title":"Chin Med J"},{"key":"654_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jcin.2008.07.003","volume":"1","author":"JR Costa Jr","year":"2008","unstructured":"Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, et al. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment ofsingle de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. JACC Cardiovasc Interv. 2008;1:545\u201351.","journal-title":"JACC Cardiovasc Interv"},{"key":"654_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.12.024","volume":"233","author":"EP Navarese","year":"2014","unstructured":"Navarese EP, Kowalewski M, Cortese B, Kandzari D, Dias S, Wojakowski W, et al. Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. Atherosclerosis. 2014;233:224\u201331.","journal-title":"Atherosclerosis"},{"key":"654_CR18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/hrt.2009.172379","volume":"95","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Kufner S, Tiroch K, Massberg S, Laugwitz KL, Birkmeier A, et al. Randomised trial of three rapamycin-elutingstents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. Heart. 2009;95:1489\u201394.","journal-title":"Heart"},{"key":"654_CR19","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1002\/ccd.24375","volume":"81","author":"L King","year":"2013","unstructured":"King L, Byrne RA, Mehilli J, Sch\u00f6mig A, Kastrati A, Pache J. Five-yearclinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stented and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial. Catheter Cardiovasc Interv. 2013;81:E23\u20138. doi: 10.1002\/ccd.24375 .","journal-title":"Catheter Cardiovasc Interv"},{"key":"654_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ccd.25131","volume":"83","author":"T Stiermaier","year":"2014","unstructured":"Stiermaier T, Heinz A, Schloma D, Kleinertz K, D\u00e4nschel W, Erbs S, et al. Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial). Catheter Cardiovasc Interv. 2014;83:418\u201324.","journal-title":"Catheter Cardiovasc Interv"},{"key":"654_CR21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2016.01.009","volume":"9","author":"S Kufner","year":"2016","unstructured":"Kufner S, Sorges J, Mehilli J, Cassese S, Repp J, Wiebe J, et al. Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-YearResults of the ISAR-TEST-5 Trial. JACC Cardiovasc Interv. 2016;9:784\u201392.","journal-title":"JACC Cardiovasc Interv"},{"key":"654_CR22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","volume":"30","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, et al. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. Eur Heart J. 2009;30:923\u201331.","journal-title":"Eur Heart J"},{"key":"654_CR23","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","volume":"55","author":"RA Byrne","year":"2010","unstructured":"Byrne RA, Kastrati A, Tiroch K, Schulz S, Pache J, Pinieck S, et al. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents. J Am Coll Cardiol. 2010;55:2536\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"654_CR24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"S Massberg","year":"2011","unstructured":"Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J, et al. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stented and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus-Eluting Stents (ISAR-TEST 5). Circulation. 2011;124:624\u201332.","journal-title":"Circulation"},{"key":"654_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-5922.2012.00319.x","volume":"31","author":"SL Chen","year":"2013","unstructured":"Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, et al. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial. Cardiovasc Ther. 2013;31:193\u2013200.","journal-title":"Cardiovasc Ther"},{"key":"654_CR26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ccd.24473","volume":"81","author":"J Watt","year":"2013","unstructured":"Watt J, Kennedy S, McCormick C, Agbani EO, McPhaden A, Mullen A, et al. Succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model. Catheter Cardiovasc Interv. 2013;81:698\u2013708.","journal-title":"Catheter Cardiovasc Interv"},{"key":"654_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrcardio.2012.64","volume":"9","author":"F Otsuka","year":"2012","unstructured":"Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R. The importance of the endothelium in atherothrombosis and coronary stented. Nat Rev Cardiol. 2012;9:439\u201353.","journal-title":"Nat Rev Cardiol"},{"key":"654_CR28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ccd.25140","volume":"83","author":"S Murase","year":"2014","unstructured":"Murase S, Suzuki Y, Yamaguchi T, Matsuda O, Murata A, Ito T. The relationship between re-endothelialization and endothelial function after DES implantation: comparison between paclitaxcel eluting stent and zotarolims eluting stent. Catheter Cardiovasc Interv. 2014;83:412\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"key":"654_CR29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.0000155612.47040.17","volume":"111","author":"D Fukuda","year":"2005","unstructured":"Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation. 2005;111:926\u201331.","journal-title":"Circulation"},{"key":"654_CR30","first-page":"1021","volume":"34","author":"P Zhang","year":"2006","unstructured":"Zhang P, Huang L, Zhu GX, Cui B, Song MB, Zhou YP, et al. Sirolimus inhibits the differentiation, proliferation and migration of endothelial progenitor cells in vitro. Zhonghua Xin Xue Guan Bing Za Zhi. 2006;34:1021\u20135.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"654_CR31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2184.2006.00375.x","volume":"39","author":"TG Chen","year":"2006","unstructured":"Chen TG, Chen JZ, Wang XX. Effects of rapamycin on number activity and eNOS ofendothelial progenitor cells from peripheral blood. Cell Prolif. 2006;39:117\u201325.","journal-title":"Cell Prolif"},{"key":"654_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tcm.2012.05.007","volume":"21","author":"B Ho-Tin-No\u00e9","year":"2011","unstructured":"Ho-Tin-No\u00e9 B, Michel JB. Initiation of angiogenesis in atherosclerosis: smoothmuscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med. 2011;21:183\u20137.","journal-title":"Trends Cardiovasc Med"},{"key":"654_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","volume":"63","author":"AS Jaipersad","year":"2014","unstructured":"Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes inangiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63:1\u201311.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0654-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T08:32:13Z","timestamp":1719390733000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0654-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0654-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2017,8,15]]},"article-number":"222"}}